---
category: listing
circular_id: 5d38576772079100
date: '2025-12-15'
description: Dr. Lal PathLabs Limited announces bonus issue of 1 equity share for
  every 1 existing share with record date December 19, 2025 and effective listing
  date December 23, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={CC1487B6-53FA-42D2-8517-A51AD38059FF}&noticeno=20251215-9&dt=12/15/2025&icount=9&totcount=72&flag=0
impact: high
impact_ranking: high
importance_ranking: high
justification: High impact due to 1:1 bonus ratio doubling outstanding shares for
  a listed company. High importance for existing shareholders as it affects shareholding
  and trading.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251215-9&attachedId=5e437086-f919-4b2c-9ebb-696d54e556b6
processing:
  attempts: 1
  content_hash: a70bab73d57d4310
  processed_at: '2025-12-15T19:04:32.166271'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-15T08:49:29+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={CC1487B6-53FA-42D2-8517-A51AD38059FF}&noticeno=20251215-9&dt=12/15/2025&icount=9&totcount=72&flag=0
severity: medium
source: bse
stocks:
- LALPATHLAB
tags:
- bonus-issue
- corporate-action
- equity-shares
- dr-lal-pathlabs
- record-date
title: Bonus Issue of Dr. Lal PathLabs Limited - 1:1 Ratio
---

## Summary

Dr. Lal PathLabs Limited (Scrip Code: 539524/139524) has confirmed the record date of December 19, 2025 for its bonus issue. The company will issue 1 bonus equity share of Rs. 10/- each for every 1 existing equity share held. The company has undertaken to credit bonus shares to beneficiary accounts by 12 P.M. on December 22, 2025 (deemed allotment date), with shares available for trading from December 23, 2025.

## Key Points

- Bonus ratio: 1:1 (one bonus share for every one existing share)
- Total bonus shares to be issued: 8,37,75,510 equity shares of Rs. 10/- each
- Face value of bonus shares: Rs. 10/- each
- ISIN: INE600L01024
- In-Principle Approval from BSE already obtained
- Scrutinizer's Report uploaded on BSE Listing Centre 3 working days before record date
- Distinctive number range: 83775511 to 167551020

## Regulatory Changes

No regulatory changes. This is a corporate action disclosure as per listing compliance requirements.

## Compliance Requirements

- Company has obtained In-Principle Approval from BSE
- Company has uploaded Scrutinizer's Report on BSE Listing Centre 3 working days before record date
- Company undertakes to credit bonus shares to beneficiary accounts by 12 P.M. on deemed allotment date
- Company confirms shares will be available for trading from the effective listing date

## Important Dates

- **December 12, 2025**: Communication sent to BSE
- **December 19, 2025**: Record Date for determining eligible shareholders
- **December 22, 2025**: Deemed Date of Allotment (shares to be credited by 12 P.M.)
- **December 23, 2025**: Effective Listing Date (shares available for trading)

## Impact Assessment

**Market Impact:** High - The 1:1 bonus ratio will double the outstanding equity shares of Dr. Lal PathLabs Limited, potentially improving liquidity and making shares more accessible to retail investors. The share price is expected to adjust proportionately after the bonus issue.

**Shareholder Impact:** High - Existing shareholders as of record date will receive equal number of additional shares at no cost, doubling their shareholding while maintaining their proportionate ownership in the company.

**Trading Impact:** Trading in the stock will reflect the bonus adjustment from December 23, 2025 onwards, with the stock price expected to trade at approximately half the pre-bonus price (adjusted for the 1:1 ratio).